Technology areas: Chemistry & Materials • Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Discgenics Inc. has 3 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are distributed among 3 distinct examiners and 2 distinct art units. This indicates that each pending matter is being reviewed by a different official, which prevents any single examiner's habits from dominating the portfolio's overall progress. The use of 2 distinct art units suggests the company's medical device filings cover at least 2 technical sub-specialties within the broader field.
FAROOQ, MAHMOOD is the busiest examiner, responsible for 1 pending office action. With 3 examiners for 3 actions, the workload is evenly distributed among the assigned officials. This distribution means that the company must navigate the individual preferences of 3 different examiners while also managing filings in 2 separate art units. The concentration in 2 art units rather than 3 indicates that at least 2 of the 3 pending actions share a similar technical classification, even if they are handled by different examiners.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FAROOQ, MAHMOOD | 1 | 60.0% | +0.0% |
| BOSWORTH, KAMI A | 1 | 69.1% | +28.7% |
| ABEL, LENORA A | 1 | 68.3% | +34.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18254120 | METHODS AND SYSTEMS FOR TREATMENT OF INTERVERTEBRAL DISC BY INTRADISCAL MICRO-NEEDLE INSERTION | BOSWORTH, KAMI A | 28d |
| 18526510 | CAPPED SYRINGES AND METHODS OF SEALING SAME | FAROOQ, MAHMOOD | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16490419 | DEVICES, METHODS, AND COMPOSITIONS USEFUL IN CRYO-PRESERVATION, -STORAGE, -TRANSPORT, AND APPLICATION OF THERAPEUTIC MAMMALIAN CELLS | ABEL, LENORA A | 15d overdue |
| 18254120 | METHODS AND SYSTEMS FOR TREATMENT OF INTERVERTEBRAL DISC BY INTRADISCAL MICRO-NEEDLE INSERTION | BOSWORTH, KAMI A | 28d |
| Art Unit | Apps |
|---|---|
| 3783 | 2 |
| 1799 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18526510 | CAPPED SYRINGES AND METHODS OF SEALING SAME | FAROOQ, MAHMOOD | 3783 | §102§103 | Non-Final OA | — | Pending | Dec 01, 2023 |
| 18254120 | METHODS AND SYSTEMS FOR TREATMENT OF INTERVERTEBRAL DISC BY INTRADISCAL MICRO-NEEDLE INSERTION | BOSWORTH, KAMI A | 3783 | §102§103§112 | Non-Final OA | 28d | Pending | May 23, 2023 |
| 16490419 | DEVICES, METHODS, AND COMPOSITIONS USEFUL IN CRYO-PRESERVATION, -STORAGE, -TRANSPORT, AND APPLICATION OF THERAPEUTIC MAMMALIAN CELLS | ABEL, LENORA A | 1799 | §103 | Non-Final OA | 15d overdue | Pending | Aug 30, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial